Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, was among the thousands of FDA employees who lost their jobs due to a restructuring initiative by the Department of Health and Human Services aimed at saving $1.8 billion annually. Analysts warn that Marks’ departure could affect the regulatory guidance for the development of biologic medicines, particularly in the area of cell and gene therapies.
Hackers hit Ukrainian state agencies, critical infrastructure with new ‘Wrecksteel’ h
Ukraine suffered three cyberattacks in March targeting government agencies and critical infrastructure using a new spy malware called ‘Wrecksteel’. Ukraine’s computer emergency response team (CERT-UA)
